Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Int'l Equity | 98.7% |
---|---|
US Equity | 0.6% |
Cash | 0.4% |
Other | 0.3% |
CDN Equity | 0 |
Fixed Income | 0 |
Financial Serv.s | 19.6% |
---|---|
Industrials | 16.8% |
Healthcare | 14.1% |
Consumer Cyclical | 9.9% |
Technology | 9.6% |
Consumer Defensive | 8.6% |
Basic Mat. | 6.5% |
Communication Services | 4.9% |
Energy | 4.0% |
Utilities | 3.1% |
Real Estate | 2.3% |
Asia/Oceania | 35.2% |
---|---|
Europe | 31.9% |
United States | 0.6% |
Africa | 0 |
Latin America | 0 |
Canada | 0 |
Company Name sortable | Position sortable | Allocation sortable | Allocation sortable1 Month Change | Market Value sortable |
---|---|---|---|---|
Novo Nordisk AS Class B | Long | 2.6% | -0.40% | $94.0K |
ASML Holding NV | Long | 2.0% | -3.28% | $71.5K |
Nestle SA | Long | 1.7% | -0.95% | $60.6K |
AstraZeneca PLC | Long | 1.6% | -1.64% | $56.4K |
Novartis AG Registered Shares | Long | 1.4% | -0.97% | $49.5K |
SAP SE | Long | 1.3% | -1.83% | $47.5K |
Roche Holding AG | Long | 1.2% | -2.02% | $44.3K |
Lvmh Moet Hennessy Louis Vuitton SE | Long | 1.1% | -4.65% | $41.2K |
Shell PLC | Long | 1.1% | -1.09% | $38.9K |
Toyota Motor Corp | Long | 1.1% | 0.00% | $38.3K |
The Morningstar ETF Report offers in-depth analyst research on exchange-traded funds to help you evaluate these investments and how they fit within a portfolio.
Time Horizon | Star Rating |
---|---|
Overall Rating | 4 out of 5 Stars |
3 Year Rating | 4 out of 5 Stars |
5 Year Rating | Not Rated |
10 Year Rating | Not Rated |
Past performance is no guarantee of future results. The ratings reflect historical risk-adjusted performance, and the overall rating is derived from a weight average of the fund's 3, 5, and 10 year (Morningstar Rating) metrics.
Style Box is calculated only using the long position holdings of the portfolio.
Best Fit Index | SB Des Dev exUSexCA RI LC NR CAD |
---|---|
Category | |
Sponsor | Desjardins Global Asset Management Inc |
Inception | May 1, 2020 |
DRMD seeks to provide long-term capital appreciation and to gradually reduce the portfolio’s Financed Emissions while managing active risk. To achieve this, it invests primarily in equity and equity-related securities of large and mid-cap companies in developed markets (ex-USA ex-Canada) while ensuring that all Constituent Issuers meet Pre-Determined ESG Standards.
Total Net Assets | $5.1M |
---|---|
Shares Out. | 200.0K |
Net Asset Value (NAV) | $24.72 |
Prem/Discount to NAV | 0.13% |
P/E Ratio | 16.7 |
Dividend Yield | 12.54% |
Dividend per Share | --- |
Ex-Dividend Date | --- |
Dividend Payment Date | --- |
Beta | --- |
Morningstar Investment Style | International Equity |
Equity Style | Large Cap Blend |
Credit Quality / Duration | --- |
Actual Management Fee | 0.25% |
---|---|
Actual Mgmt. Expense Ratio (MER) | 0.29% |